Descriptor English: | Roscovitine | ||||||
Descriptor Spanish: |
Roscovitina
| ||||||
Descriptor Portuguese: | Roscovitina | ||||||
Descriptor French: | Roscovitine | ||||||
Entry term(s): |
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol 2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine CYC 202 CYC-202 CYC202 R roscovitine R-roscovitine Seliciclib |
||||||
Tree number(s): |
D03.633.100.759.776 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077546 | ||||||
Scope note: | A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antineoplastic Agents Antiviral Agents Protein Kinase Inhibitors |
||||||
Registry Number: | 0ES1C2KQ94 | ||||||
Public MeSH Note: | 2019; ROSCOVITINE was indexed under PURINES 1997-2018 |
||||||
History Note: | 2019 (1997) |
||||||
DeCS ID: | 57671 | ||||||
Unique ID: | D000077546 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/09 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Roscovitine
- Preferred
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
- Related but not broader or narrower
CYC 202
- Narrower
R-roscovitine
- Narrower
Seliciclib
- Narrower
Concept UI |
M0273114 |
Scope note | A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent. |
Preferred term | Roscovitine |
Entry term(s) |
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol |
Concept UI |
M000640881 |
Preferred term | 2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine |
Concept UI |
M0462906 |
Preferred term | CYC 202 |
Entry term(s) |
CYC-202 CYC202 |
Concept UI |
M0489548 |
Preferred term | R-roscovitine |
Entry term(s) |
R roscovitine |
Concept UI |
M0489549 |
Preferred term | Seliciclib |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey